|
NAME: Ellen S. Vitetta POSITION TITLE: Director/Professor
EDUCATION/TRAINING: Connecticut College, New London, CT, BA, 1964; NYU Graduate School, New York, NY, MS, 1966
NYU Graduate School, New York, NY, Ph.D, 1968
PROFESSIONAL EXPERIENCE: 1976 - Present Professor, Department of Microbiology, UTSWMC; 1984 - 1988 Chairperson, Immunology Graduate Program, UTSWMC; 1988 - Present Director, Cancer Immunobiology Center, Scheryle Simmons Patigian Distinguished Chair in Cancer Immunology, UTSWMC
PROFESSIONAL SOCIETIES, CONFERENCES, COMMITTEES (1990-2005): Councilor, International Society of Immunopharmacology, 1991-; Co-Editor in Chief, Therapeutic Immunology, 1992-1997;Scientific Advisory Board, Howard Hughes Medical Institute, 1992-1995; NCI Division of Cancer Treatment, Board of Scientific Counselors, 1993-1994; Vice President and President, American Association of Immunologists, 1993-1995; Association for Women in Science, 1994-; Board of Scientific Counselors, Office of AIDS Research, 1995-1996; National Research Council, 2001-.
AWARDS (1990-2007): NIH Merit Award, 1987-1997; Faculty Teaching Award, 1989, 1991-1996, 1999-2004; FASEB Excellence in Science Award, 1991; The Gibson D. Lewis Award for Cancer Control (Research Achievement), Texas Cancer Council, 1991; Abbott Clinical Immunology Award, American Society for Microbiologists, 1992; Past State President’ Award of the Texas Federation of Business and Professional Women’s Clubs, 1993; National Academy of Sciences, 1994; President, American Association of Immunologists, 1994-1995; UCLA Distinguished Professorship, 1994; Kinyoun Lecture, NIAID, NIH, 1994; Rosenthal Award, American Association for Cancer Research, 1995; College Medal, Connecticut College, 1997; America Women in Medicine, Distinguished Scientist Award, 1998; Academy of Cancer Immunology, 2001; National Research Council Liason/NAS, 2001; American Association of Immunologists, Distinguished Mentoring Award, 2002; American Association for Cancer Research Charlotte Friend Award and Lecture, 2002; American Academy of Arts & Sciences Member, 2003; Texas Academy of Sciences, Member, 2004; Alpha Omega Alpha Honor Medical Society, Member, 2004; Southwestern Academy of Teachers, 2006; Texas Women?s Hall of Fame Award, 2006; UT Academy of Health Science Eduation, 2006; The Texas Academy of Medicine, Engineering and Science, 2006; National Academy of Science Institute of Medicine, 2006; Lifetime Achievement Award, American Association of Immunologists, 2007
Publications 480 total)
1. Smallshaw, J.E., Firan, A., Fulmer, J.R., et al. A Novel Recombinant Vaccine which Protects Mice Against Ricin Intoxication. Vaccine, 20:3422-3427., 2002.
2. Smallshaw, J.E., Ghetie, V., Rizo, J., et al. Genetic engineering of an immunotoxin to eliminate its ability to induce pulmonary vascular leak in mice. Nat. Biotechnol. 21:387-391,2003.
3. Spiridon, CI, Gunn, S. and Vitetta, E.S. A comparison of the in vitro activities of IgG and F(ab)2 fragments of a mixture of three monoclonal anti-Her-2 antibodies. Clin Can Res 10:3542-3551, 2004.
4. Ghetie, M-A., Marches, R., Kufert, S., Vitetta, E.S. An anti-CD19 antibody inhibits the interaction between P-gp and CD19, causes P-gp to translocate out of lipid rafts and chemosensitizes a MDR lymphoma cell line. Blood 104:1, 178-183, 2004.
5. Smallshaw, J.E., Coleman, E., Spiridon, C., Vitetta, E.S. The generation and anti-myeloma activity of a chimeric anti-CD54 antibody, cUV3. J. Immunol 27:6,419-424,2004.
6. Pop, L. M., Liu, X, Ghetie, V., and Vitetta, E.S. The generation of immunotoxins using chimeric anti-CD22 antibodies containing mutations which alter their serum half life. International Immunopharmacology, 5/7-8, 1279-1290, 2005.
7. Smallshaw, J., Richardson, J.A., Pincus, S., et al. Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against Ricin. Vaccine, 23:4775-4784, 2005. |
